Abstract:Injectable biomaterials are attractive for soft tissue regeneration because they are handled in a minimally invasive manner and can easily adapt to complex defects. However, inadequate vascularization of the injectable constructs has long been a barrier, leading to necrosis or volume reduction after implantation. In this work, we developed a three-step process to synthesize injectable gelatin-derived hydrogels that are capable of controlling growth factor delivery to induce angiogenesis. In our approach, tyramine was first introduced into gelatin chains to provide enzymatic crosslinking points for gel formation after injection. Next, heparin, a polysaccharide with binding domains to many growth factors, was covalently linked to the tyramine-modified gelatin. Finally, vascular endothelial growth factor (VEGF) was incorporated into the gelatin derivative by binding with the heparin in the gelatin derivative, and an injectable gel with controlled VEGF release was formed by an enzymatic catalytic reaction with hydrogen peroxide (H2O2) and horseradish peroxidase (HRP). The gelation time, mechanical properties and degradation of the gel was readily tailored by the gelatin concentration and the ratio of H2O2/HRP. Binding VEGF to heparin stabilizes this growth factor, protects it from denaturation and proteolytic degradation and subsequently prolongs the sustained release. An in vitro release study and bioactivity assay indicated that the VEGF was released in a sustained manner with high bioactivity for over 3 weeks. Furthermore, a chicken chorioallantoic membrane (CAM) assay and animal experiments were performed to evaluate in vivo bioactivity of the VEGF released from the hydrogels. After 5 days of incubation on CAM, the number of blood vessels surrounding the heparin-modified hydrogels was increased by 2.4-fold compared with that of the control group. Deeper and denser cell infiltration and angiogenesis in the heparin-modified gelatin/VEGF gels were observed compared to the controls after being subcutaneously injected in the dorsal side of the mice for 2 weeks. Interestingly, even without the incorporation of VEGF, the heparin-modified gelatin derivative still had the capability to induce angiogenesis to a certain degree. Our results suggest that the gelatin derivative/VEGF is an excellent injectable delivery system for induced angiogenesis of soft tissue regeneration.

Enhanced Vascularization in Hybrid PCL/Gelatin Fibrous Scaffolds with Sustained Release of VEGF

Enhanced Cellular Function of Human Vascular Endothelial Cell on Poly (Ε-Caprolactone)/gelatin Coaxial-Electrospun Scaffold

Enhanced Vascularization of PCL Porous Scaffolds Through VEGF-Fc Modification

Functional Modification of Fibrous PCL Scaffolds with Fusion Protein VEGF-HGFI Enhanced Cellularization and Vascularization.

Functional Modification of Fibrous PCL Scaffolds with Fusion Protein HGFI-VEGF Enhanced Cellularization and Vascularization

Poly(ethylene glycol) Hydrogels with the Sustained Release of Hepatocyte Growth Factor for Enhancing Vascular Regeneration.

In Vitro Evaluation of Panax Notoginseng Rg1 Released from Collagen/chitosan-Gelatin Microsphere Scaffolds for Angiogenesis

Injectable gelatin derivative hydrogels with sustained vascular endothelial growth factor release for induced angiogenesis

In vitro and in vivo evaluation of a novel collagen/cellulose nanocrystals scaffold for achieving the sustained release of basic fibroblast growth factor

Promotion of angiogenesis by sustained release of rhGM-CSF from heparinized collagen/chitosan scaffolds.

Controlled release of chitosan/heparin nanoparticle-delivered VEGF enhances regeneration of decellularized tissue-engineered scaffolds.

Polydopamine-modified Konjac Glucomannan Scaffold with Sustained Release of Vascular Endothelial Growth Factor to Promote Angiogenesis

Performance of a multilayered small-diameter vascular scaffold dual-loaded with VEGF and PDGF.

Gelatin Coating Promotes In Situ Endothelialization Of Electrospun Polycaprolactone Vascular Grafts

Functional Modification of Electrospun Poly(ε-caprolactone) Vascular Grafts with the Fusion Protein VEGF–HGFI Enhanced Vascular Regeneration

VEGF-Fc delivery scaffold for promoting angiogenesis in biomaterials

Rapid Endothelialization and Controlled Smooth Muscle Regeneration by Electrospun Heparin-Loaded Polycaprolactone/gelatin Hybrid Vascular Grafts

Use of Heparinized Bacterial Cellulose Based Scaffold for Improving Angiogenesis in Tissue Regeneration.

Enhancement of VEGF-Mediated Angiogenesis by 2-N,6-o-sulfated Chitosan-Coated Hierarchical PLGA Scaffolds.

Sustained delivery of vascular endothelial growth factor using a dextran/poly(lactic-co-glycolic acid)-combined microsphere system for therapeutic neovascularization

Hydrogel Complex Electrospun Scaffolds and Their Multiple Functions in in Situ Vascular Tissue Engineering